APLT - Applied Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
New York,
United States
Type: Equity
APLT price evolution
APLT
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $49.9 | $37.46 | $35.62 | $22.92 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $54.39 | $44.49 | $42.82 | $29.06 |
| Long term investments | ||||
| Property, plant & equipment | $0.45 | $0.51 | $0.63 | $0.74 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.45 | $0.71 | $0.82 | $0.94 |
| Total investments | ||||
| Total assets | $54.83 | $45.2 | $43.65 | $30 |
| Current liabilities | ||||
| Accounts payable | $1.74 | $6 | $4.69 | $5.55 |
| Deferred revenue | ||||
| Short long term debt | $0.43 | $0.49 | $0.49 | $0.48 |
| Total current liabilities | $71.18 | $55.5 | $47.19 | $33.25 |
| Long term debt | $0.04 | $0.04 | $0.17 | $0.29 |
| Total noncurrent liabilities | $0.8 | $0.73 | $0.79 | $0.82 |
| Total debt | $0.47 | $0.54 | $0.66 | $0.77 |
| Total liabilities | $71.98 | $56.24 | $47.98 | $34.08 |
| Shareholders' equity | ||||
| Retained earnings | -$468.59 | -$430.91 | -$388.54 | -$358.96 |
| Other shareholder equity | ||||
| Total shareholder equity | -$17.15 | -$11.04 | -$4.33 | -$4.07 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $49.9 | $16.66 | $53.89 | $57.47 |
| Short term investments | $13.92 | $26.93 | $39.36 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $54.39 | $37.31 | $88.39 | $102.59 |
| Long term investments | ||||
| Property, plant & equipment | $0.45 | $0.86 | $1.3 | $1.71 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.45 | $1.05 | $1.5 | $1.91 |
| Total investments | $13.92 | $26.93 | $39.36 | |
| Total assets | $54.83 | $38.36 | $89.89 | $104.51 |
| Current liabilities | ||||
| Accounts payable | $1.74 | $4.53 | $9.46 | $0.64 |
| Deferred revenue | ||||
| Short long term debt | $0.43 | $0.48 | $0.44 | $0.41 |
| Total current liabilities | $71.18 | $33.42 | $26.46 | $21.23 |
| Long term debt | $0.04 | $0.41 | $0.89 | $1.33 |
| Total noncurrent liabilities | $0.8 | $0.88 | $0.89 | $1.33 |
| Total debt | $0.47 | $0.89 | $1.33 | $1.74 |
| Total liabilities | $71.98 | $34.3 | $27.35 | $22.57 |
| Shareholders' equity | ||||
| Retained earnings | -$468.59 | -$348.82 | -$266.31 | -$160.73 |
| Other shareholder equity | $0.05 | -$0.11 | -$0.11 | |
| Total shareholder equity | -$17.15 | $4.06 | $62.54 | $81.94 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | -$0.67 | $10.66 | ||
| Cost of revenue | ||||
| Gross Profit | -$0.67 | $10.66 | ||
| Operating activities | ||||
| Research & development | $15.3 | $10.79 | $11.88 | $15.94 |
| Selling, general & administrative | $5.04 | $4.71 | $5.29 | $5.58 |
| Total operating expenses | $20.34 | $15.49 | $17.18 | $21.52 |
| Operating income | -$21.01 | -$15.49 | -$17.18 | -$10.86 |
| Income from continuing operations | ||||
| EBIT | -$37.68 | -$42.37 | -$29.58 | -$10.14 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$37.68 | -$42.37 | -$29.58 | -$10.14 |
| Income (for common shares) | -$37.68 | -$42.37 | -$29.58 | -$10.14 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9.99 | |||
| Cost of revenue | ||||
| Gross Profit | $9.99 | |||
| Operating activities | ||||
| Research & development | $53.91 | $55.63 | $62.57 | $61.79 |
| Selling, general & administrative | $20.62 | $27.32 | $43.05 | $32.68 |
| Total operating expenses | $74.53 | $82.95 | $105.62 | $94.47 |
| Operating income | -$64.53 | -$82.95 | -$105.62 | -$94.47 |
| Income from continuing operations | ||||
| EBIT | -$119.76 | -$82.51 | -$105.03 | -$93.4 |
| Income tax expense | ||||
| Interest expense | $0.56 | $0.56 | ||
| Net income | ||||
| Net income | -$119.76 | -$82.51 | -$105.58 | -$93.96 |
| Income (for common shares) | -$119.76 | -$82.51 | -$105.58 | -$93.96 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$37.68 | -$42.37 | -$29.58 | -$10.14 |
| Operating activities | ||||
| Depreciation | $0.01 | $0.12 | $0.12 | $0.11 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.63 | $1.84 | $1.84 | $2.06 |
| Total cash flows from operations | -$17 | -$14.73 | -$16.45 | -$6.99 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $13.87 | |||
| Total cash flows from investing | $13.87 | |||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $29.91 | $6.78 | $27.91 | |
| Net borrowings | -$0.47 | -$0.47 | $1.24 | -$0.62 |
| Total cash flows from financing | $29.45 | $16.57 | $29.15 | -$0.62 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $12.44 | $1.84 | $12.7 | $6.26 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$119.76 | -$82.51 | -$105.58 | -$93.96 |
| Operating activities | ||||
| Depreciation | $0.35 | $0.44 | $0.41 | $0.38 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.36 | $9.6 | $11.18 | $8.03 |
| Total cash flows from operations | -$55.17 | -$78.09 | -$90.73 | -$78.21 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $13.87 | $13.17 | $12.43 | -$19.47 |
| Total cash flows from investing | $13.87 | $13.17 | $12.43 | -$19.47 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $64.6 | $27.86 | $74.93 | $135.92 |
| Net borrowings | -$0.31 | -$0.17 | -$0.28 | $1.07 |
| Total cash flows from financing | $74.54 | $27.69 | $74.72 | $136.29 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $33.24 | -$37.23 | -$3.58 | $38.62 |
News
Fundamentals
| Market cap | $372.58M |
|---|---|
| Enterprise value | $323.15M |
| Shares outstanding | 84.87M |
| Revenue | $9.99M |
|---|---|
| EBITDA | -$119.41M |
| EBIT | -$119.76M |
| Net Income | -$119.76M |
| Revenue Q/Q | -InfinityT% |
| Revenue Y/Y | N/A |
| P/E ratio | -3.11 |
|---|---|
| EV/Sales | 32.34 |
| EV/EBITDA | -2.71 |
| EV/EBIT | -2.70 |
| P/S ratio | 37.28 |
| P/B ratio | -21.73 |
| Book/Share | -0.20 |
| Cash/Share | 0.59 |
| EPS | -$1.41 |
|---|---|
| ROA | -275.83% |
| ROE | 1.31K% |
| Debt/Equity | -4.20 |
|---|---|
| Net debt/EBITDA | -0.18 |
| Current ratio | 0.76 |
| Quick ratio | 0.76 |